BackSolid Biosciences Overview

Solid Biosciences Current Cash

Track Solid Biosciences's current cash ($300M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$297.74M
↑ 41.36% YoYΔ $87.11M vs prior year quarter

Peer average

Loading

Solid Biosciences Current Cash History

Loading

Solid Biosciences vs. peers: Current Cash Comparison

Loading

Solid Biosciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Solid Biosciences (SLDB) FAQ

As of the most recent data (March 2026), SLDB shows a current cash of $300M. That compares with $210M in the prior-year period — up 41.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SLDB's current cash is now $300M (was $210M) — a 41.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Solid Biosciences is outperforming or lagging.

Tracking SLDB's current cash over time shows whether Solid Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $300M That compares with $210M in the prior-year period — up 41.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Solid Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $300M) with ownership activity and broader fundamentals.

Solid Biosciences's current cash is $300M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.